Search Results - Toyin Adewole

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    A Phase II Double-Blind, Placebo-Controlled, Efficacy and Safety Study of SPN-812 (Extended-Release Viloxazine) in Children With ADHD

    A Phase II Double-Blind, Placebo-Controlled, Efficacy and Safety Study of SPN-812 (Extended-Release Viloxazine) in Children With ADHD by Janet Johnson, Tesfaye Liranso, Keith E. Saylor, Gabriela Tulloch, Toyin Adewole, Stefan Schwabe, Azmi Nasser, Robert L. Findling, Jeffrey H. Newcorn

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children

    A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hypera... by Azmi Nasser, Tesfaye Liranso, Toyin Adewole, Nicholas Fry, Joseph T. Hull, Fatima Chowdhry, Gregory D. Busse, Andrew J. Cutler, Nandita Joshi Jones, Robert L. Findling, Stefan Schwabe

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder

    A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder by Azmi Nasser, Tesfaye Liranso, Toyin Adewole, Nicholas Fry, Joseph T. Hull, Gregory D. Busse, Fatima Chowdhry, Andrew J. Cutler, Nandita Joshi Jones, Robert L. Findling, Stefan Schwabe

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: